coronavirus vaccine they developed and began testing in April 2020. The research was funded £20 million ($24 million) gr

[answerhappygod]

Coronavirus Vaccine They Developed And Began Testing In April 2020 The Research Was Funded 20 Million 24 Million Gr 1 (72.13 KiB) Viewed 170 times

Coronavirus Vaccine They Developed And Began Testing In April 2020 The Research Was Funded 20 Million 24 Million Gr 2 (38.59 KiB) Viewed 170 times

coronavirus vaccine they developed and began testing in April 2020. The research was funded £20 million ($24 million) grant from the U.K.'s National Health Service. The vaccine was made from a weakened version of a common cold virus that causes infections chimpanzees. It was modified to make it impossible to grow in humans. Proteins from the Covic virus's outer coat were then added. "We hoped the body would recognize and develop an immu response to the COVID-19 protein that will help stop the SARS-CoV-2 virus from entering huma cells and therefore prevent infection," the University said. In the trial 1,068 volunteers were recruited. They were assigned by a flip of a coin to either be injected with the coronavirus vaccine or to receive a control - a widely available meningitis vaccin Volunteers, who lived in a variety of locations around the U.K., were then followed for 6 months. The researchers performed laboratory tests each week to determine if the volunteers had contracted COVID-19 (the disease caused by the coronavirus). The following are the results of the study: Number of people Number of cases of COVID-19 Number of COVID-19 deaths 527 53 (10.0%) 15 (2.8%) People who received the coronavirus vaccine People who received the meningitis vaccine 541 97 (17.9%) 31 (5.7%) "Mortality rate is based on the number of people in the study group. Mortality rate can be calculated based on population total or number of cases.

Number of people Number of cases of COVID-19 Number of COVID-19 deaths 527 53 (10.0%) 15 (2.8%) People who received the coronavirus vaccine People who received the meningitis vaccine 541 97 (17.9%) 31 (5.7%) "Mortality rate is based on the number of people in the study group. Mortality rate can be calculated based on population total or number of cases. Question: In the experimental design, what is the experimental (test) group in this experiment? People who received the coronavirus vaccine. Number of COVID-19 cases Number of males tested People who received the meningitis vaccine, Number of females tested.